To find the recommended dose of the combination of avutometinib, defactinib, and everolimus in patients with endometrial cancer that is recurrent and has abnor…

Phase IBAvutometinibRAS Pathway+1 more

~Estimated

~$150 – $3,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07318324

Phase 1

Zotatifin And EIF4A Platinum Helix Inhibition In Resistant AdvancedTNBC

To find the optimal (best) recommended dose of zotatifin and carboplatin to treat patients with metastatic or recurrent TNBC.

Phase IBZotatifinEIF4A+2 more

~Estimated

~$150 – $3,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07783659